Cognition Therapeutics
Cognition Therapeutics is a biotechnology and pharmaceutical company developing therapeutics for Alzheimer’s disease and other neurodegenerative disorders that is headquartered in Pittsburgh, Pennsylvania in 2007 by Gilbert Rishton and Susan Catalano.
4
Funding Rounds
$49.6m
Money raised
Overview
Cognition Therapeutics is a biotechnology and pharmaceutical company developing therapeutics for Alzheimer’s disease and other neurodegenerative disorders that is headquartered in Pittsburgh, Pennsylvania in 2007 by Gilbert Rishton and Susan Catalano.
| Name | Phone | Social networks | |
|---|---|---|---|
| Gi***** M. Ri***** |
|
- | |
| Su*** Ca****** | - | - | - |
| Name | Phone | Social networks | |
|---|---|---|---|
| Ja** A. Kh***** | - | - | |
| Aa*** Fl****** | - | - | - |
| Br*** P. Mo*** | - | - | |
| Li** Ri******* | - | - | - |
| Pe*** Wa***** | - | - | - |
Funding
Funding series
Funding Series Analysis
The company Cognition Therapeutics has raised a total of $49.61m in funding over 4 rounds.
Key Insights:
- Cognition Therapeutics Initial public offering (IPO): $45.2m
- Cognition Therapeutics Series B round: $3m
- Cognition Therapeutics Series A round: $1.21m
- Cognition Therapeutics funding round, November 2007: $200k
Cognition Therapeutics Initial public offering (IPO)
$45.2m
Cognition Therapeutics Series B round
$3m
Cognition Therapeutics Series A round
$1.21m
Cognition Therapeutics funding round, November 2007
$200k
Industries
Cognition Therapeutics is active in the following industries:
- Therapeutics
- Biopharmaceutical
- Drug discovery
- Neuroscience
- Biomedical engineering
- Engineering
- Technology
- Biology
- Biotechnology
- Alzheimer's disease
- Neurodegenerative Disease